Justin R Kingery1,2,3, Parag Goyal1,4, Rahul Hosalli3, Myung Hee Lee3, Bernard Desderius2, Fredrick Kalokola2, Abel Makubi2, Salama Fadhil5, Saidi Kapiga5, Dipan Karmali6, Daniel Kaminstein7, Richard Devereux4, Margaret McNairy1,3, Warren Johnson3, Daniel Fitzgerald3, Robert Peck1,2,3,5. 1. Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York, USA. 2. Department of Internal Medicine, Weill Bugando School of Medicine, Mwanza, Tanzania. 3. Center for Global Health, Department of Internal Medicine, Weill Cornell Medicine, New York, New York, USA. 4. Division of Cardiovascular Medicine, Weill Cornell Medicine, New York, New York, USA. 5. Mwanza Intervention Trials Unit, London School of Hygiene and Tropical Medicine, Mwanza, Tanzania. 6. Division of General Internal Medicine, Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA. 7. Center for Ultrasound Education, Department of Emergency Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
Abstract
BACKGROUND: The aims of this study were (1) to compare the prevalence of myocardial diastolic dysfunction (DD) in antiretroviral therapy (ART)-naive people living with human immunodeficiency virus (PLWH) to human immunodeficiency virus (HIV)-uninfected adults in East Africa and (2) to determine the association between serum concentration of the cardiac biomarkers ST2 and DD. METHODS: In this cross-sectional study, we enrolled PLWH and uninfected adults at a referral HIV clinic in Mwanza, Tanzania. Standardized history, echocardiography, and serum were obtained. Regression models were used to quantify associations. RESULTS: We enrolled 388 ART-naive PLWH and 461 HIV-uninfected adults with an average age of 36.0 ± 10.2 years. Of PLWH in the third, fourth, and fifth decades of life, 5.0%, 12.5%, and 32.7%, respectively, had DD. PLWH had a higher prevalence of DD (adjusted odds ratio, 2.71 [95% confidence interval, 1.62-4.55]; P < .0001). PLWH also had a higher probability of dysfunction with one or fewer traditional risk factors present. Serum ST2 concentration was associated with dysfunction in PLWH but not uninfected participants (P = .04 and P = .90, respectively). CONCLUSIONS: In a large population of young adults in sub-Saharan Africa, DD prevalence increased starting in the third decade of life. HIV was independently associated with dysfunction. Serum ST2 concentration was associated with DD in PLWH but not HIV-uninfected participants. This pathway may provide insight into the mechanisms of HIV-associated dysfunction.
BACKGROUND: The aims of this study were (1) to compare the prevalence of myocardial diastolic dysfunction (DD) in antiretroviral therapy (ART)-naive people living with human immunodeficiency virus (PLWH) to human immunodeficiency virus (HIV)-uninfected adults in East Africa and (2) to determine the association between serum concentration of the cardiac biomarkers ST2 and DD. METHODS: In this cross-sectional study, we enrolled PLWH and uninfected adults at a referral HIV clinic in Mwanza, Tanzania. Standardized history, echocardiography, and serum were obtained. Regression models were used to quantify associations. RESULTS: We enrolled 388 ART-naive PLWH and 461 HIV-uninfected adults with an average age of 36.0 ± 10.2 years. Of PLWH in the third, fourth, and fifth decades of life, 5.0%, 12.5%, and 32.7%, respectively, had DD. PLWH had a higher prevalence of DD (adjusted odds ratio, 2.71 [95% confidence interval, 1.62-4.55]; P < .0001). PLWH also had a higher probability of dysfunction with one or fewer traditional risk factors present. Serum ST2 concentration was associated with dysfunction in PLWH but not uninfected participants (P = .04 and P = .90, respectively). CONCLUSIONS: In a large population of young adults in sub-Saharan Africa, DD prevalence increased starting in the third decade of life. HIV was independently associated with dysfunction. Serum ST2 concentration was associated with DD in PLWH but not HIV-uninfected participants. This pathway may provide insight into the mechanisms of HIV-associated dysfunction.
Authors: Sameer Ather; Wenyaw Chan; Biykem Bozkurt; David Aguilar; Kumudha Ramasubbu; Amit A Zachariah; Xander H T Wehrens; Anita Deswal Journal: J Am Coll Cardiol Date: 2012-03-13 Impact factor: 24.094
Authors: Justin R Kingery; Yona Alfred; Luke R Smart; Emily Nash; Jim Todd; Mostafa R Naguib; Jennifer A Downs; Samuel Kalluvya; Johannes B Kataraihya; Robert N Peck Journal: Heart Date: 2016-04-22 Impact factor: 5.994
Authors: Kristin E Mondy; John Gottdiener; E Turner Overton; Keith Henry; Tim Bush; Lois Conley; John Hammer; Charles C Carpenter; Erna Kojic; Pragna Patel; John T Brooks Journal: Clin Infect Dis Date: 2010-12-09 Impact factor: 9.079
Authors: Gautam Nayak; Michael Ferguson; David R Tribble; Chad K Porter; Robert Rapena; Marc Marchicelli; Catherine F Decker Journal: AIDS Patient Care STDS Date: 2009-04 Impact factor: 5.078
Authors: Priscilla Y Hsue; Peter W Hunt; Jennifer E Ho; Husam H Farah; Amanda Schnell; Rebecca Hoh; Jeffrey N Martin; Steven G Deeks; Ann F Bolger Journal: Circ Heart Fail Date: 2009-11-20 Impact factor: 8.790
Authors: Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer Journal: JAMA Date: 2003-01-08 Impact factor: 56.272
Authors: Risa M Hoffman; Florence Chibwana; Ben Allan Banda; Daniel Kahn; Khumbo Gama; Zachary P Boas; Mayamiko Chimombo; Chiulemu Kussen; Judith S Currier; Dan Namarika; Joep van Oosterhout; Sam Phiri; Agnes Moses; Jesse W Currier; Hitler Sigauke; Corrina Moucheraud; Tim Canan Journal: Open Heart Date: 2022-05
Authors: Bethel Woldu; Tecla M Temu; Nicholas Kirui; Bridgette Christopher; Samson Ndege; Wendy S Post; Jemima Kamano; Gerald S Bloomfield Journal: Open Heart Date: 2022-01